Skip to content

A Study to Compare Individualized Homoeopathic Medicines and Harad (Terminalia chebula) in the Treatment of Irritable Bowel Syndrome.

Efficacy of Individualized Homoeopathic Medicines Versus Terminalia Chebula mother tincture in the management of Irritable Bowel Syndrome- A single-blind randomized controlled trial. - NIL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/110046
Enrollment
90
Registered
2026-05-05
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K582- Mixed irritable bowel syndrome

Interventions

Intervention1: Individualized Homoeopathic Medicines: A single individualized homoeopathic medicine will be prescribed based on totality of symptoms and repertorial analysis. The medicine will be admi

Sponsors

R.B.T.S. Government Homoeopathic Medical College And Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients between 18 to 50 years of age and willing to participate in the study. 2 Score of more than 75 on Irritable Bowel Syndrome- Symptom severity scale (IBS SSS). 3 Cases of both sexes.

Exclusion criteria

Exclusion criteria: 1 Patients with other severe systemic illnesses, malignant disorders, autoimmune diseases or any organic disease. 2 Patients above 50 years of age. 3 Any major surgery in the last 6 months. 4 Patients under other medication for the same complaint. 5 Patients with cognitive impairment. 6 Pregnant women and lactating mothers

Design outcomes

Secondary

MeasureTime frame
change in Quality of Life using EQ-5D Questionnaire from baseline to 12 weeks of treatment.Timepoint: 12 weeks

Primary

MeasureTime frame
change in IBS Symptom Severity Scale (IBS-SSS) from baseline to 12 weeks of treatment.Timepoint: 12 weeks

Countries

India

Contacts

Public ContactDr Pravin Kumar Singh

R.B.T.S. Government Homoeopathic Medical College And Hospital

drpravinsingh83@gmail.com9430001076

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026